These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6356402)

  • 41. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.
    Weidmann P
    Drug Saf; 2001; 24(15):1155-65. PubMed ID: 11772148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indapamide: a diuretic of choice for the treatment of hypertension?
    Clarke RJ
    Am J Med Sci; 1991 Mar; 301(3):215-20. PubMed ID: 1825743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperlipidemia of diuretic therapy.
    Ames R
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The possible mode of action of indapamide: a review.
    Campbell DB
    Curr Med Res Opin; 1983; 8 Suppl 3():9-24. PubMed ID: 6352188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diuretic and cardiovascular effects of indapamide in hypertensive subjects: a dose-response curve.
    Leenen FH; Smith DL; Boer WH; Marquez-Julio A
    Curr Med Res Opin; 1983; 8 Suppl 3():47-52. PubMed ID: 6352185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The place of indapamide in the treatment of arterial hypertension.
    Thénot A
    Curr Med Res Opin; 1983; 8 Suppl 3():140-4. PubMed ID: 6617238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertensive effect of indapamide with special emphasis on renal prostaglandin production.
    LeBel M; Grose JH; Belleau LJ; Langlois S
    Curr Med Res Opin; 1983; 8 Suppl 3():81-6. PubMed ID: 6578003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension.
    Borghi L; Elia G; Trapassi MR; Melloni E; Amato F; Barbarese F; Novarini A
    Pharmacology; 1988; 36(5):348-55. PubMed ID: 3406047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical, endocrine, and mineral effects of indapamide in black women.
    Prisant LM; Beall SP; Nichoalds GE; Feldman EB; Carr AA; Feldman DS; Hames CG
    J Clin Pharmacol; 1990 Feb; 30(2):121-6. PubMed ID: 2179276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular effects of indapamide in hypertensive patients with or without renal failure. A dose-response curve.
    Leenen FH; Smith DL; Farkas RM; Boer WH; Reeves RA; Marquez-Julio A
    Am J Med; 1988 Jan; 84(1B):76-85. PubMed ID: 3341390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension.
    Pedersen EB; Danielsen H; Spencer ES
    Eur J Clin Pharmacol; 1984; 26(5):543-7. PubMed ID: 6468469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preclinical studies of indapamide, a new 2-methylindoline antihypertensive diuretic.
    Pruss T; Wolf PS
    Am Heart J; 1983 Jul; 106(1 Pt 2):208-11. PubMed ID: 6869202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. An Italian multicenter study.
    Leonetti G; Rappelli A; Salvetti A; Scapellato L
    Am J Med; 1988 Jan; 84(1B):59-64. PubMed ID: 3277420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum lipoproteins during treatment with the antihypertensive agent indapamide.
    Gerber A; Weidmann P; Bianchetti MG; Ferrier C; Laederach K; Mordasini R; Riesen W; Bachmann C
    Hypertension; 1985; 7(6 Pt 2):II164-9. PubMed ID: 4077235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of indapamide on phosphate metabolism and vascular reactivity.
    Plante GE; Lafreniere MC; Tam PT; Sirois P
    Am J Med; 1988 Jan; 84(1B):26-30. PubMed ID: 3277416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
    Acchiardo SR; Skoutakis VA
    Am Heart J; 1983 Jul; 106(1 Pt 2):237-44. PubMed ID: 6346847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of the acute and chronic administration of indapamide on systemic and renal haemodynamics in essential hypertension.
    Villarreal H; Nuñez-Poissot E; Anguas MC; Degandarias L; Meza U
    Curr Med Res Opin; 1983; 8 Suppl 3():135-9. PubMed ID: 6617237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.